Mitsubishi to acquire Medicago at $1.16 per share
Japan | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...Read more
Kinetic launches portable negative pressure therapy
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Apr, 2013
Singapore: US-based Kinetic Concepts (KCI) has launched ActiVAC Therapy System for in-patient use in Japan, which is a l...Read more
Terumo and Biosensors to sell Nabori DES system
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Terumo and Biosensors International announced an extension of their existing licensing agreements, under w...Read more
Otsuka, Lundbeck files NDA for schizophrenia drug
Japan | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...Read more
HealthPatch MD receives Japanese nod
Japan | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2015
Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in th...Read more
Amgen-Cytokinetics collaboration to include Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2013
Singapore: USA-based Amgen, the world's largest independent biotech company, has expanded its strategic collaboration wi...Read more
Taiho seeks Japanese nod for oral cancer agent
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2013
Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral...Read more
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (F...Read more
Innovative dual chamber syringe for pharma market
Japan | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new typ...Read more
Takeda to acquire LigoCyte Pharma
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned sub...Read more
BioJapan to kick off in October
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: The 17th edition of BioJapan is all set to kick off from October 14, 2015 Pacifico Yokohama. Top industry pla...Read more
Takeda, Resolve to develop, sell autoimmune drugs
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2013
Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the t...Read more
Takeda acquires LigoCyte Pharmaceuticals at $60 mn
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...Read more
GlobalData: Osteoporosis market to be $8 bn
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...Read more
R-Tech Ueno loses case against Takeda
Japan | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2012
Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in t...Read more
APAC ovarian cancer drug market to grow modestly'
Japan | Analysis | By BioSpectrum Bureau | 2 Comment | 30 Jan, 2015
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...Read more
Agenix gets patent for ThromboView in Japan
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Japan's Patent Office has granted a key patent to drug and diagnostic company Agenix covering the manufacturi...Read more
Deal with Janssen gets Astellas $65 million up-front
Japan | News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2012
Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...Read more